Monoclonal antibodies against c-Met
Abstract:
Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0